tizanidine
NDC 76420-886, tizanidine, tablet, from Asclemed USA, Inc..
- Product NDC
- 76420-886
- Status
- Listed
- Labeler
- Asclemed USA, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208187
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76420-886 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIZANIDINE HYDROCHLORIDE4 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76420-886-00 | 76420088600 | 1000 TABLET in 1 BOTTLE (76420-886-00) |
| 76420-886-01 | 76420088601 | 100 TABLET in 1 BOTTLE (76420-886-01) |
| 76420-886-03 | 76420088603 | 300 TABLET in 1 BOTTLE (76420-886-03) |
| 76420-886-11 | 76420088611 | 10 TABLET in 1 BLISTER PACK (76420-886-11) |
| 76420-886-15 | 76420088615 | 15 TABLET in 1 BOTTLE (76420-886-15) |
| 76420-886-21 | 76420088621 | 150 TABLET in 1 BOTTLE (76420-886-21) |
| 76420-886-30 | 76420088630 | 30 TABLET in 1 BOTTLE (76420-886-30) |
| 76420-886-60 | 76420088660 | 60 TABLET in 1 BOTTLE (76420-886-60) |
| 76420-886-88 | 76420088688 | 10 TABLET in 1 BOTTLE (76420-886-88) |
| 76420-886-90 | 76420088690 | 90 TABLET in 1 BOTTLE (76420-886-90) |
| 76420-886-99 | 76420088699 | 10 BLISTER PACK in 1 CARTON (76420-886-99) / 10 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a9ba9023-0c3f-4c9b-ba8e-d39d23bf35d6
Use it
Look up 76420-886 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76420-886 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76420-886. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.